Schonfeld Strategic Advisors’s GoHealth GOCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-14,613
Closed -$78K 2758
2022
Q3
$78K Hold
14,613
﹤0.01% 2596
2022
Q2
$131K Buy
14,613
+1,280
+10% +$14.9K ﹤0.01% 2065
2022
Q1
$236K Buy
13,333
+12,613
+1,752% +$393K ﹤0.01% 1843
2021
Q4
$41K Sell
720
-3,727
-84% -$249K ﹤0.01% 1959
2021
Q3
$336K Buy
4,447
+3,574
+409% +$378K ﹤0.01% 1471
2021
Q2
$147K Sell
873
-3,194
-79% -$559K ﹤0.01% 1746
2021
Q1
$714K Sell
4,067
-3,160
-44% -$637K 0.01% 1018
2020
Q4
$1.48M Buy
7,227
+3,467
+92% +$644K 0.02% 686
2020
Q3
$735K Buy
+3,760
New +$905K 0.01% 797

Other funds holding GOCO

Schonfeld Strategic Advisors's GOCO Position: Q4 2022 in Review

Schonfeld Strategic Advisors sold out of GoHealth (GOCO) in Q4 2022, closing a stake of 14,613 shares — an estimated $78K sold.

Schonfeld Strategic Advisors first reported a position in GOCO in Q3 2020 and held it in 9 quarters. The position peaked at $1.48M in Q4 2020. 35 funds tracked by Wall St. Rank hold GOCO as of Q4 2022.

  • Schonfeld Strategic Advisors reported no remaining GoHealth position as of Q4 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 14,613 GoHealth shares in Q4 2022, an estimated $78K.
  • Schonfeld Strategic Advisors first reported a position in GoHealth in Q3 2020 and held it in 9 quarters.
  • Schonfeld Strategic Advisors's GoHealth position peaked at $1.48M in Q4 2020.
  • 35 funds tracked by Wall St. Rank held GoHealth as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.